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A number of diseases that lead to injury of the central nervous system are caused by oxidative stress and inﬂammation in the brain.
In this study, NNMBS275, consisting of the ethanol extract of Viola patrinii, showed potent antioxidative and anti-inﬂammatory
activity in murine hippocampal HT22 cells and BV2 microglia. NNMBS275 increased cellular resistance to oxidative injury caused
by glutamate-induced neurotoxicity and reactive oxygen species generation in HT22 cells. In addition, the anti-inﬂammatory
eﬀects of NNMBS275 were demonstrated by the suppression of proinﬂammatory mediators, including proinﬂammatory enzymes
(inducible nitric oxide synthase and cyclooxygenase-2) and cytokines (tumor necrosis factor-α and interleukin-1β). Furthermore,
we found that the neuroprotective and anti-inﬂammatory eﬀects of NNMBS275 were linked to the upregulation of nuclear
transcription factor-E2-related factor 2-dependent expression of heme oxygenase-1 in HT22 and BV2 cells. These results suggest
that NNMBS275 possesses therapeutic potential against neurodegenerative diseases that are induced by oxidative stress and
neuroinﬂammation.
1.Introduction
Brain tissues are vulnerable to oxidative stress, which may
occurphysiologically as a component of the aging process, or
pathologically as a result of neurodegenerative disease [1, 2].
Oxidative stress, or the accumulation of reactive oxygen
species (ROS), not only results in accidental damage to cells,
but also actively triggers intracellular signaling pathways that
lead to cell death. Neuronal oxidative stress has been pos-
tulated to be the underlying basis for neuronal cell death in
neurodegenerative diseases such as Alzheimer’s disease and
Parkinson’s disease [3–5]. Glutamate is the main excitatory
neurotransmitter in the central nervous system (CNS).
However, at high concentrations, glutamate has been shown
to induce neuronal cell death via both receptor-initiated
excitotoxicity and non-receptor-mediated oxidative stress
[6, 7]. In this study, immortalized mouse hippocampal
HT22 cells were used as in vitro models for studying
the mechanism of oxidative glutamate toxicity. Glutamate-
induced neurotoxicity in HT22 cells has been characterized
as an intracellular process attributable to the inhibition
of cystine uptake via the cystine/glutamate antiporter sys-
tem Xc−, eventually leading to programmed cell death
due to glutathione depletion and accumulation of ROS
[8, 9].
Heme oxygenase 1 (HO-1), also referred to as HSP32,
belongs to the HSP family and protects mammalian cells
from oxidative stress by degrading toxic heme into free
iron, carbon monoxide, and biliverdin/bilirubin. Although
HO-1 does not directly catalyze an antioxidant reaction, its
induction is generally considered an adaptive cytoprotective
response against the toxicity of oxidative stress [10–12]. The2 Evidence-Based Complementary and Alternative Medicine
induction of HO-1 is primarily regulated at the transcrip-
tional level, and its induction by various inducers is related
to the nuclear transcription factor-E2-related factor 2 (Nrf2)
[13]. Nrf-2 is a basic leucine zipper transcription factor that
resides in the cytoplasm bound to its inhibitor protein, Keap
1, and translocates to the nucleus after stimulation. It then
forms heterodimers with small oncogene family proteins for
the selective recognition of the antioxidant responsive ele-
ment on target genes, resulting in the regulation of gene ex-
pression of phase II detoxifying enzymes, including HO-1
[14, 15]. HO-1 induction occurs in a wide variety of cells, in-
cluding neuronal and nonneuronal brain cells. Previous
studieshavereportedthatthecerebellargranulecellsharvest-
ed from transgenic mice designed to overexpress HO-1 in
neurons appear to be relatively resistant to H2O2-mediat-
ed oxidative damage in vitro [16]. Furthermore, several re-
searchers have reported that phytochemicals, such as resver-
atrol, curcumin, and epigallocatechin-3-gallate, exhibit the
significant therapeutic beneﬁt in the case of oxidative stress-
induced neuronal damage via the induction of HO-1 [17–
19].
Alongwithneuronaloxidativestress,neuroinﬂammation
also contributes to the pathogenesis of several neurodegen-
erative disorders [20, 21]. Microglia, the immunocompetent
resident cells of the brain, play the main role in innate
immune defense in the CNS. Several studies have shown
that excessive activation of microglia increases neurotoxicity
and, therefore, contributes to neuronal injury through the
release of various proinﬂammatory cytokines and inﬂamma-
tory mediators such as nitric oxide (NO), prostaglandins,
tumor necrosis factor (TNF)-α, and interleukin (IL)-1β
[22–25]. In addition to its antioxidative eﬀects, recent
studies have also demonstrated anti-inﬂammatory eﬀects
of HO-1 in a number of inﬂammation models [26–29].
The anti-inﬂammatory action of HO-1 is mediated by
inhibiting the production of proinﬂammatory cytokines and
chemokines such as TNF-α,I L - 1 β, and IL-6 in activated
macrophages. HO-1 and its product, carbon monoxide, can
also suppress the expression of proinﬂammatory COX-2 and
iNOS, thereby reducing the production of COX-2-derived
prostaglandin E2 (PGE2) and iNOS-derived NO [30–33].
The anti-inﬂammatory action of HO-1 in microglia has also
been reported. Therefore, regulating the degree of generation
of oxidative stress and microglial activation viathe upregula-
tion of HO-1 may be considered an important intervention
in formulating a strategy for the treatment of neurological
diseases.
Violae herba has been widely used in traditional Chinese
medicine to treat carbuncles, boils, and other cutaneous and
subcutaneous pyogenic infections. Sources of violae herba
include Viola patrinii, V. hederacea, V. arvensis, and V. odor-
ata. Previous phytochemical studies of Viola species have
reported the isolation of cyclotides and several ﬂavonoid gly-
cosides[34–37].However,littleisknownaboutthebiological
activities of these plants. As a part of ongoing research to
identify natural products that can induce HO-1 expression
in vitro, we have shown here that the ethanol extract of V.
patrinii(NNMBS275)wasshowntosigniﬁcantlyincreasethe
levels of HO-1 in both BV2 microglia and HT22 cells.
2.MaterialsandMethods
2.1. Chemicals and Reagents. Dulbecco’s modiﬁed Eagle’s
medium (DMEM), fetal bovine serum (FBS), and other
tissue culture reagents were purchased from GIBCO BRL
Co. (Grand Island, NY, USA). Tin protoporphyrin IX (SnPP
IX; inhibitor of HO activity) was obtained from Porphyrin
Products (Logan, UT, USA). Cobalt protoporphyrin IX
(CoPP; HO-1 inducer), Trolox, and all other chemicals were
obtained from Sigma Chemical Co. (St. Louis, MO, USA).
TRIzol reagent and a polymerase chain reaction (PCR)
kit were purchased from Invitrogen Corporation (Carlsbad,
CA, USA). Primary antibodies, including mouse/goat/rabbit
anti-HO-1, anti-COX-2, and anti-iNOS, and secondary
antibodies were purchased from Santa Cruz Biotechnology
(Santa Cruz, CA, USA). Enzyme-linked immunosorbent
assay (ELISA) kits for PGE2,T N F - α,a n dI L - 1 β were
purchased from R & D Systems, Inc. (Minneapolis, MN,
USA).
2.2. Plant Material and Preparation of NNMBS275. The
aerial parts of Viola patrinii DC (Violaceae) were collected in
the Botanical Garden of Wonkwang University, Iksan, Korea,
in June 2010. A voucher specimen (no. WP2010-26) was
authenticated by Dr. Kyu-Kwan Jang, the Botanical Garden
of Wonkwang University, and deposited at the herbarium
of the College of Pharmacy, Wonkwang University. Dried
and pulverized V. patrinii (50g) was extracted twice with
ethanol (300mL) at room temperature for 3 days, and the
extract was concentrated in vacuo to obtain an ethanol
extract (NNMBS275, 720mg). NNMBS275 was deposited at
the Standardized Material Bank for New Botanical Drugs,
Wonkwang University. For each experiment, NNMBS275
was dissolved in dimethylsulfoxide (ﬁnal culture concen-
tration, 0.05%). Serum-free medium was used as a vehicle
control. Preliminary studies indicated that the solvent had
no eﬀect on cell viability at the concentration used.
2.3. High-Performance Liquid Chromatography (HPLC).
Chromatographic experiments were performed on a
SNKNM series HPLC instrument equipped with a sample
injector and a diode-assay UV/Vis detector (DAD) (SYKAM,
Germany). For all experiments, an Inertsil ODS C-18
column (4.6 × 150nm; 5μm, GL Science Inc., Tokyo, Japan)
was used as the stationary phase, and the injection volume
was 20μL. The mobile phase was composed of water (A)
and acetonitrile (B), with an applied gradient of 20% B
increasing to 60% B in 40min. The column was cleaned
with 10% B for 20min, and then the system was equilibrated
for 20min with the starting conditions. Flow rate was
0.7mL/min, and the detection wavelength was adjusted to
210nm.
2.4. Cell Culture and Viability Assay. Mouse hippocampal
HT22 cells were received from Prof. In-Hee Mook at Seoul
National University (Seoul, Korea), and BV2 microglia cells
werereceivedfromProf.HyunParkatWonkwangUniversity.
The cells were maintained at 5 × 105 cells/mL in DMEMEvidence-Based Complementary and Alternative Medicine 3
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Figure 1: HPLC chromatogram of EtOH extract from V. patrinii.
medium supplemented with 10% heat-inactivated FBS,
100U/mL penicillin G, 100mg/L streptomycin, and 2mM
L-glutamine, and incubated at 37◦C in a humidiﬁed atmo-
sphere containing 5% CO2 and 95% air. For determination
of cell viability, 50mg/mL of 3-[4,5-dimethylthiazol-2-yl]-
2,5-diphenyltetrazolium bromide (MTT) was added to 1mL
of cell suspension (1 × 105 cells per 1mL in 96-well plates)
and incubated for 4h. The formazan formed was dissolved
in acidic 2-propanol, and optical density was measured at
590nm.
2.5.Reactive OxygenSpecies Measurement. For measurement
ofROS,HT22cells(2.5 ×104 cells/mLin24-wellplates)were
treated with 5mM glutamate in the presence or absence of
NNMBS275 or SnPP (HO inhibitor) and incubated for 8h.
Afterwashingwithphosphate-buﬀeredsaline(PBS),thecells
were stained with 10μM2  ,7 -dichloroﬂuorescein diacetate
in Hanks’ balanced salt solution for 30min in the dark. The
cells were then washed twice with PBS and extracted using
1%TritonX-100inPBSfor10minat37◦C.Fluorescencewas
recorded at an excitation wavelength of 490nm and emission
wavelength of 525nm (Spectramax Gemini XS; Molecular
Devices, Sunnyvale, CA, USA).
2.6. Nitrite Assay. The method used for the determination of
NO production follows the protocol published by Lee et al.
[38]. The nitrite concentration in the medium was measured
as an indicator of NO production as per the Griess reaction.
100μL of each supernatant was mixed with the same volume
of Griess reagent, and the absorbance of the mixture at
525nm was determined with an ELISA plate reader.
2.7. PGE2,T N F - α,a n dI L - 1 β Assay. BV2 microglia were
cultured in 24-well plates, preincubated for 12h with various
concentrationsofNNMBS275,andthentreatedfor18hwith
lipopolysaccharide (LPS). Culture medium was collected
and the concentration of PGE2,T N F - α,a n dI L - 1 β was
determined using ELISA kits (R&D Systems) as per the
manufacturer’s instructions.
2.8. Western Blot Analysis. H T 2 2a n dB V 2c e l l sw e r eh a r -
vested and pelleted at 200×g for 3min, washed with PBS,
and lysed with 20mM Tris-HCl buﬀer (pH 7.4) containing
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Figure 2: Eﬀects of NNMBS275 on cell viability. (a) BV2 microglia
and (b) HT22 cells were incubated for 12h with various concentra-
tions of NNMBS275 (25–300μg/mL). Cell viability was determined
as described in Section 2. Bar represents the mean ± S.D. of 3
independent experiments.
a protease inhibitor mixture (0.1mM phenylmethanesul-
fonyl ﬂuoride (PMSF), 5mg/mL aprotinin, 5mg/mL pep-
statin A, and 1mg/mL chymostatin). Protein concentration
was determined using a Lowry protein assay kit (P5626;
Sigma). An equal amount of protein from each sample was
resolved using 12% sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) and then electrophoretically
transferred onto a Hybond-enhanced chemiluminescence
(ECL) nitrocellulose membrane (Bio-Rad, Hercules, CA,
USA). The membrane was blocked with 5% skimmed milk
and incubated with anti-HO-1, anti-iNOS, anti-COX-2,
anti-Nrf2, anti-IκB-α, anti- phospho-IκB-α, anti-p65, anti-
PCNA, or anti-β-actin (all antibodies were used at a 1:1000
dilutionandwerepurchasedfromSantaCruzBiotechnology,
CA, USA) antibodies at 4◦C overnight. The immunoreactive
bands were visualized by horseradish peroxidase-conjugated4 Evidence-Based Complementary and Alternative Medicine
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Figure 3: Eﬀects of NNMBS275 on LPS-induced inducible iNOS and COX-2 protein expression and NO, PGE2, and proinﬂammatory
cytokine levels in BV2 microglia. BV2 microglia were pretreated for 12h with indicated concentrations of NNMBS275 and stimulated for
1 8hw i t hL P S( 0 . 5μg/mL). Western blot analyses for iNOS and COX-2 expression (a and b) were performed as described in Section 2.
Representative blots of 3 independent experiments are shown. The concentrations of NO, PGE2, tumor necrosis TNF-α,a n dI L - 1 β (c, d, e,
and f) were determined as described under Section 2. Data represent mean values of 3 experiments ± S.D. ∗P<0.05 compared to the group
treated with LPS.
secondary antibody (1:1000 dilution, Santa Cruz Biotech-
nology) followed by ECL detection (Amersham Pharmacia
Biotech, Piscataway, NJ, USA) and quantitated using an
image program (Image Gauge v3.12 software, Fujiﬁlm,
Tokyo, Japan).
2.9. Preparation of Nuclear and Cytosolic Fractions. Cells
were homogenized (1:20, w:v) in PER-mammalian protein
extraction buﬀer (Pierce Biotechnology, Rockford, IL, USA)
containing freshly added protease inhibitor cocktail I (EMD
Biosciences, San Diego, CA, USA) and 1mM PMSF. The
cytosolic fraction of the cell was prepared by centrifugation
at 15,000×gf o r1 0 m i na t4 ◦C. Nuclear and cytoplasmic
extracts of HT22 cells and BV2 cells were prepared, using
NE-PER nuclear and cytoplasmic extraction reagents (Pierce
Biotechnology), respectively. After treatment, cells (3 ×
106 cells/3mL in 60mm dish) were collected and washed
with PBS. After centrifugation, cell lysis was performed at
4◦C by vigorous shaking for 15min in RIPA buﬀer (150mM
NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1%
SDS, 50mM Tris-HCl [pH 7.4], 50mM glycerophosphate,
20mM NaF, 20mM ethylene glycol tetraacetic acid, 1mM
dithiothreitol, 1mM Na3VO4, and protease inhibitors). After
centrifugation at 14,800×g for 15min, the supernatant was
separated and stored at −70◦C until further use. Protein
content was determined using the bicinchoninic acid protein
assay kit (Pierce Biotechnology, Rockford, IL, USA).Evidence-Based Complementary and Alternative Medicine 5
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Figure 4: Eﬀects of NNMBS275 on glutamate-induced oxidative
neurotoxicity, and inhibition of ROS generation in HT22 cells.
(a) Cells were pretreated for 12h with indicated concentrations
of NNMBS275 and then incubated for 12h with glutamate
(5mM). (b) Exposure of HT22 cells to 5mM glutamate for
12h increased ROS production. NNMBS275 eﬀectively inhibited
glutamate-mediated ROS production. Data represent mean values
of 3 experiments ± S.D. ∗P<0.05 compared to the group treated
with glutamate. Trolox (50μM) was used as a positive control.
2.10. RNA Quantiﬁcation. Total RNA was extracted from
cells harvested for reverse transcription polymerase chain
reaction (RT-PCR) using the TRIzol System (Invitrogen).
The RNA isolation protocol included a DNase I treatment.
WequantiﬁedRNAandreversetranscribedcDNAsfrom1μg
of total RNA per 20μL RT reaction with Oligo (dT) 12-8
primer and the SuperScript First-Strand Synthesis System
for RT-PCR (Invitrogen). RT-PCR was conducted in a 25μL
solution containing 67.7mM Tris-HCL (pH 8.8); 16.6mM
(NH4)2SO4; 0.01% Tween-20; 200nM each of dATP, dCTP,
dGTP, and 400nM dUTP; 4.5mM MgCl2; 300nM of each
primer; 200nM probe; 2U Taq DNA polymerase, and 1/10
(byvolume)ofthecDNAsynthesisreaction.Thermalcycling
conditions consisted of 4min at 95◦C followed by 25 cycles
o f1 5 sa t9 5 ◦C and 1min at 60◦C. PCR was carried out
with following primers for HO-1 (375bp, Forward: 5 -TGA
AGG AGG CCA CCA AGG AGG-3 ,R e v e r s e :5  -AGA GGT
CAC CCA GGT AGC GGG-3 ), and actin (514bp, Forward:
5 -TGT GAT GGT GGG AAT GGG TCA G-3 ,R e v e r s e :5  -
TTT GAT GTC ACG CAC GAT TTC C-3 ). The annealing
temperatures were 55◦C for HO-1 and 58◦C for actin.
2.11. DNA-Binding Activity of NF-κB. BV2 cells were
pretreated for 12h with the indicated concentrations of
NNMBS275 and stimulated for 1h with LPS. The DNA-
binding activity of NF-κB in nuclear extracts was measured
(TransAM kit; Active Motif, Carlsbad, CA, USA) according
to the manufacturer’s instructions. Brieﬂy, the following
procedure was used: add 30μL complete-binding buﬀer
(DTT,herring spermDNA,andbinding buﬀerAM3)to each
well. Add 20μL of samples, the indicated concentrations of
NNMBS275, and stimulated for 1h with LPS on BV2 cells,
diluted in complete lysis buﬀer per well (20μgo fn u c l e a r
extract diluted in complete lysis buﬀer). Incubate for 1h at
roomtemperaturewithmildagitation(100rpmonarocking
platform). After washing each well with wash buﬀer, 100μL
of diluted NF-κB antibody (1:1000 dilution in 1 × Antibody
Binding Buﬀer) was added to each well and then incubated
for 1h with mild agitation (100rpm on a rocking platform).
After washing each well with wash buﬀer, 100μL of diluted
HRP-conjugated antibody (1:1000 dilution in 1 × Antibody
Binding Buﬀer) was added to each well and then incubated
for 1h with mild agitation (100rpm on a rocking platform).
Developing solution was added to each well and left to react
for 5min followed by a wash to remove the supernatant.
The 450-nm absorbance of each sample was then read on a
spectrophotometer within 5min.
2.12. Statistical Analysis. Data were expressed in terms of
the mean ± S.D. of at least 3 independent experiments. To
compare 3 or more groups, one-way analysis of variance was
used followed by a Newman-Keuls post hoc test. Statistical
analysis was performed using GraphPad Prism software
version 3.03 (GraphPad Software Inc, San Diego, CA, USA).
3. Results
3.1. HPLC Analysis of NNMBS275. Data from the HPLC
analysis of NNMBS275 was recorded in the form of chro-
matograms by monitoring detector responses at 210nm. As
shown in Figure 1, according to the HPLC ﬁngerprint, there
were3peaksintheextract.AlthoughV.patriniihasbeenlong
used as a traditional herbal medicine in China and Korea,
there are few phytochemical studies of this plant. We intend
to pursue an investigation of the chemical components of
V. patrinii in future detailed studies, in order to identify the
biological activities of this plant.
3.2. Eﬀects of NNMBS275 on Cell Viability. Initially, the
cytotoxic eﬀects of NNMBS275 on BV2 microglia and
HT22 cells were measured. The MTT assay performed at
200μg/mLNNMBS275revealednocytotoxiceﬀectsineither6 Evidence-Based Complementary and Alternative Medicine
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Figure 5: Eﬀects of NNMBS275 on HO-1 expression in BV2 microglia (a and b) and HT22 (c and d). BV2 microglia and HT22 cells were
incubated for 12h with indicated concentrations of NNMBS275 (a and c) and periods with 200μg/mL of NNMBS275 (b and d). The HO-
1 inducer CoPP, increased HO-1 expression at 20μM (a and c). Western blot analysis for HO-1 expression was performed as described
in Section 2, and representative blots of 3 independent experiments are shown. Data represent the mean values of 3 experiments ± S.D.
∗P<0.05 compared to the control group.
BV2 microglia or HT22 cells (Figure 2). Thus, for further
experiments, the cells were treated with NNMBS275 in the
concentration range of 25–200μg/mL.
3.3. Eﬀects of NNMBS275 on Proinﬂammatory Enzyme
Expression and Cytokines Production in LPS-Stimulated
BV2 Microglia. To investigate the eﬀects of NNMBS275
on iNOS and COX-2 expression in LPS-stimulated BV2
m i c r o g l i a ,c e l l sw e r et r e a t e dw i t hL P S( 0 . 5 μg/mL) in the
presence or absence of NNMBS275 at noncytotoxic con-
centrations (25–200μg/mL). Pretreatment of BV2 microglia
with NNMBS275 for 12h resulted in suppressed iNOS
expression (Figure 3(a)) and iNOS-derived NO production
(Figure 3(c)). Under the same conditions, NNMBS275 also
decreased COX-2 expression (Figure 3(b)), and COX-2-
derived PGE2 production (Figure 3(d)). Since our results
showed that NNMBS275 suppressed LPS-induced proin-
ﬂammatory mediators such as NO, iNOS, PGE2, and COX-
2, we further determined the eﬀect of NNMBS275 on LPS-
induced TNF-α and IL-1β production. The levels of these
cytokines were examined by an enzyme immunoassay in
which BV2 microglia were preincubated with NNMBS275Evidence-Based Complementary and Alternative Medicine 7
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Figure 6: Eﬀects of NNMBS275 on mRNA expression of HO-
1 in BV2 microglia and HT22. (a) BV2 microglia and (b) HT22
cells were incubated for 6h with indicated concentrations of
NNMBS275. RNA quantiﬁcation was performed as described in
Section 2, and representative blots of three independent experi-
ments are shown.
for 12h followed by LPS stimulation. As shown in Figures
3(e) and 3(f), pretreatment with NNMBS275 resulted in a
signiﬁcant and concentration-dependent decrease in TNF-α
and IL-1β production.
3.4. Eﬀect of NNMBS275 on Glutamate-Induced Cytotoxicity
and Inhibition of ROS Generation in HT22 Cells. To evaluate
the in vitro neuroprotective eﬀect of NNMBS275, we tested
its protective eﬀect on glutamate-induced cytotoxicity in
HT22 cells. Treatment with glutamate for 12h increased
HT22celldeathby55%comparedtountreatedcells,whereas
NNMBS275, at noncytotoxic concentrations (25, 50, 100,
and 200μg/mL), caused a dose-dependent increase in the
viability of these cells (Figure 4(a)). Glutamate also doubled
ROS production, and NNMBS275 eﬀectively suppressed
this induction (Figure 4(b)). Trolox, well known for its
antioxidative eﬃciency, was used as a positive control,
and it showed a signiﬁcant cytoprotective eﬀect and ROS-
scavenging activity at a concentration of 50μM.
3.5. Eﬀects of NNMBS275 on HO-1 Protein and mRNA
Expression. We examined whether noncytotoxic concentra-
tions (25–200μg / m L )o fN N M B S 2 7 5a ﬀected HO-1 protein
and mRNA expression, by treating BV2 microglia and HT22
cells with this agent for 12h. NNMBS275 caused a dose-
dependent increase in HO-1 expression in BV2 microglia
(Figure 5(a))a n dH T 2 2c e l l s( Figure 5(c)). The induction
of HO-1 by NNMBS275 reached a peak at 200μg/mL. The
HO-1 inducer CoPP, used as a positive control, increased
HO-1 expression at a dose of 20μM. At an NNMBS275
concentration of 200μg/mL, HO-1 expression showed an
increase at 6h, peaked at around 18h, and decreased after
24h in BV2 microglia and HT22 cells (Figures 5(b) and
5(d)). Consistently, NNMBS275-induced mRNA expression
levels of HO-1 also increased in a dose-dependent manner in
both BV2 microglia and HT22 cells, as assessed by RT-PCR
analysis (Figure 6).
3.6. Eﬀects of HO-1 Expression on Glutamate-Induced Oxida-
tive Neurotoxicity and Inhibition of Proinﬂammatory Medi-
ators by NNMBS275. Recent reports have described the
expression of HO-1 as an adaptive and protective response
against inﬂammation and oxidative insult in a wide variety
of cells, including glial and neuronal cells, such as BV2 and
HT22. We examined whether NNMBS275-induced HO-1
expression mediated its cytoprotective eﬀects in HT22 cells.
HT22 cells were cotreated with 200μg/mL of NNMBS275 for
12h in the absence or presence of SnPP, an inhibitor of HO-
1activity.SnPPsigniﬁcantlyinhibitedNNMBS275-mediated
cytoprotection (Figure 7(a)). NNMBS275-induced HO-1
expression was also required for suppressing glutamate-
induced ROS generation (Figure 7(b)). On the basis of
our ﬁndings that preincubation of BV2 microglia with
NNMBS275 markedly inhibited LPS-induced proinﬂamma-
tory enzymes and proinﬂammatory cytokines (Figure 3),
and that NNMBS275 was able to induce HO-1 expres-
sion (Figure 5) in BV2 microglia, we examined whether
NNMBS275-mediatedHO-1inductionmightberesponsible
for the inhibition of iNOS-derived NO, COX-2-derived
PGE2,TNF-α,andIL-1βproduction(Figures7(c),7(d),7(e),
and 7(f)). BV2 microglia were pretreated with NNMBS275
for12hinthepresenceofSnPP,followedbyLPSstimulation.
As shown in Figure 7, SnPP treatment partially reversed the
inhibitory eﬀects of NNMBS275 on NO, PGE2,T N F - α,a n d
IL-1β production.
3.7. Eﬀects of NNMBS275 on Nrf2 Nuclear Translocation.
Several studies have reported that nuclear translocation
of activated Nrf2 is an important upstream contributor
to the mechanism of HO-1 expression. Therefore, we
investigated whether treatment of BV2 microglia and HT22
cells with NNMBS275 induced the translocation of Nrf2
to the nucleus. Using western blot analysis, we tested the
presence of Nrf2 proteins in nuclear compartments of
BV2 microglia and HT22 cells. Cells were incubated with
200μg/mL NNMBS275 for 0.5, 1, and 1.5h. As shown in
Figure 8, the nuclear fractions of NNMBS275-treated BV2
microglia and HT22 cells showed a gradual increase in Nrf2
levels, whereas Nrf2 levels decreased concomitantly in the
cytoplasmic fractions.
3.8. Eﬀects of NNMBS275 on the Phosphorylation and
Degradation of IκB-α and NF-κBA c t i v a t i o n .NF-κBh a s
been implicated in the transcriptional regulation of LPS-
inducediNOSexpression.Therefore,weexaminedtheeﬀects
of NNMBS275 on the protein expression level of IκB-α
phosphorylation and degradation of IκB-α, an inhibitor
associated with NF-κB in the cytoplasm. As shown in
Figure 9(a),I κB-α w a sd e g r a d e da f t e rt r e a t m e n tw i t hL P S
in BV2 cells for 1h, and this degradation was markedly8 Evidence-Based Complementary and Alternative Medicine
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Figure 7: HO-1 mediates the suppressive eﬀect of NNMBS275 on LPS-stimulated proinﬂammatory mediator production, and glutamate-
induced oxidative neurotoxicity. (a and b) HT22 cells were pretreated for 6h with NNMBS275 (200μg/mL) in the presence or absence
of SnPP (50μM), and then incubated for 12h with glutamate (5mM). (c, d, e, and f) BV2 cells were pretreated for 3h with NNMBS275
(200μg/mL) in the presence or absence of SnPP (50μM )a n ds t i m u l a t e df o r2 4hw i t hL P S( 0 . 5μg/mL). The concentrations of NO, PGE2,
TNF-α,a n dI L - 1 β were determined as described in Section 2. SnPP was pretreated with BV2 microglia and HT22 cells for 3h in this
experiment. Data represent mean values of 3 experiments ± S.D. ∗P<0.05.
inhibited by Pretreatment of the cells with NNMBS275 (25–
200μg/mL) for 12h. These results suggest that NNMBS275
inhibited the nuclear translocation of NF-κB (p65) by the
stimulationofLPSthroughpreventionofIκB-αdegradation.
Moreover, shown in our data, the levels of nuclear p65
protein in BV2 cells were increased after treating cells with
LPS for 1h, while the level of p65 declined in response to
LPSPretreatmentwithNNMBS275(25–200μg/mL)for12h.
We also observed the appearance of NF-κB-DNA-binding
activity in nuclear extracts of BV2 cells stimulated with
LPS for 1h. As shown in Figure 9(b), treatment with LPS
alone increased the levels of NF-κB-DNA-binding activity.
However, NNMBS275 suppressed this increase in a dose-
dependent manner.
4. Discussion
Oxidative stress and inﬂammation are common in a variety
of neurodegenerative diseases, including stroke, Alzheimer’s
disease, Parkinson’s disease, and amyotrophic lateral scle-
rosis. Therefore, naturally occurring compounds having
both antioxidative and anti-inﬂammatory eﬀects may oﬀer
a promising strategy for therapeutic application. Previous
studies have demonstrated that severalnatural products such
as macelignan and xanthorrhizol have antioxidant and anti-
inﬂammatory activities in hippocampal and microglia cells
[39, 40]. HO-1, an enzyme essential for heme degradation,
has been shown to play an important role in regulating
biological responses, including oxidative stress and inﬂam-
mation. In particular, HO-1 is inducible in many neuronal
cells, including HT22 and BV2 cells. As a part of our ongoing
research to identify phytochemicals isolated from natural
sources that can induce HO-1 in vitro, the ethanol extract of
V. patrinii (NNMBS275) was shown to signiﬁcantly induce
HO-1 expression in BV2 microglia and HT22 cells.
Microglia, a resident population of macrophage-like
brain cells are believed to play a major role in host defense
and tissue repair in the CNS. Microglia are activated by a
variety of agents, including LPS, interferon (IFN)-γ,a n d
TNF-α [41–43]. Upon activation, microglia also promote
neuronal injury through the release of various proinﬂam-
matory cytokines and inﬂammatory mediators, such asEvidence-Based Complementary and Alternative Medicine 9
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Figure 8: Eﬀects of NNMBS275 on nuclear translocation of Nrf2
in BV2 cells and HT22. (a) BV2 cells and (b) HT22 cells were
treated with 200μg/mL of NNMBS275 for 0.5, 1, and 1.5h. The
nuclei were fractionated from the cytosol using PER-mammalian
p r o t e i ne x t r a c t i o nb u ﬀer as described in Section 2.N r f 2p r o t e i n
was detected by western blot analysis, and representative blots of
3 independent experiments are shown.
TNF-α and IL-1β. Several studies have also shown that
the expression of iNOS and COX-2, the key enzymes for
NO and PGE2 production, is upregulated in activated glial
cells. Pretreatment with 25–200μg/mL of NNMBS275 sup-
pressed iNOS and COX-2 expression in LPS-stimulated BV2
microglia, thereby inhibiting iNOS-derived NO as well as
COX-2-derived PGE2 production. In addition, NNMBS275
also inhibited LPS-induced TNF-α and IL-1β production.
This ﬁnding suggests that NNMBS275, at least in LPS-
stimulated microglia, exerts its anti-inﬂammatory eﬀects by
inhibiting the expression of proinﬂammatory enzymes and
the secretion of proinﬂammatory cytokines.
Glutamatetoxicity,speciﬁcallyglutamate-inducedoxida-
tive damage, is a major contributor to pathological cell death
within the nervous system and has been observed in neu-
ronal cells, including primary neuronal cells and tissue
slices. In this study, we examined the protective eﬀects
of NNMBS275 against glutamate-induced cytotoxicity in
HT22 cells. At noncytotoxic concentrations (25–200μg/mL),
NNMBS275 inhibited glutamate-induced cell death in a
dose-dependent manner 12h after treatment and also eﬀec-
tively suppressed glutamate-induced ROS generation. We
haveprovidedevidencefortheinductionofHO-1expression
by NNMBS275 in BV2 microglia and HT22 cells and
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Figure 9: Eﬀects of NNMBS275 on NF-κB activation and NF-κB
DNA-binding activity in BV2 cells. Cells were pretreated for 12h
with indicated concentrations of NNMBS275, and stimulated for
1h with LPS (0.5μg/mL). (a) Western blot analysis for IκB-α and
p-IκB-α in the cytoplasm and NF-κB expression in the nucleus was
performed as described in Section 2, and representative blots of 3
independent experiments are shown. (b) A commercially available
NF-κB ELISA (active motif) was then used to test nuclear extracts
and determine degree of NF-κB binding. Data represent the mean
values of 3 experiments ± S.D. ∗P<0.05 compared to the group
treated with LPS.
shown that NNMBS275-induced HO-1 protein and mRNA
expressionoccurredinaconcentration-andtime-dependent
manner. Furthermore, preincubation of HT22 cells with
NNMBS275 resulted in enhanced resistance to glutamate-
induced oxidative damage; this eﬀect was partly attributable
to HO-1 expression as SnPP, which inhibits HO enzyme
activity, signiﬁcantly reduced the cytoprotection aﬀorded by
NNMBS275. The induction of HO-1 expression was also
required to suppress glutamate-induced ROS generation. We
also examined whether the inhibition of PGE2,N O ,T N F -
α,a n dI L - 1 β production induced by preincubation with
NNMBS275 is mediated through HO-1 expression in BV2
cells. Indeed, SnPP also partially reversed the inhibitory10 Evidence-Based Complementary and Alternative Medicine
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Figure 10: The pathway scheme of the anti-inﬂammatory and cytoprotective eﬀects of NNMBS275 in BV2 microglia and HT22
cells. NNMBS275 increased cellular resistance to oxidative injury caused by glutamate-induced oxidative cytotoxicity in HT22 cells,
via Nrf2-dependent HO-1 expression. In BV2 cells, NNMBS275 suppressed the LPS-induced expression of proinﬂammatory enzymes
and inﬂammatory mediators through its interference of NF-κB activation and Nrf2-dependent HO-1 expression. This study indicates
that NNMBS275 eﬀectively modulates the regulation of antioxidative and anti-inﬂammatory action, via Nrf2 pathway dependent HO-1
expression in BV2 microglia and HT22 cells.
eﬀects of NNMBS275 on NO, PGE2,T N F - α,a n dI L - 1 β
production suggesting that HO-1 expression is involved in
glutamate- or LPS-induced cell responses.
HO-1 induction by low-molecular weight compounds
might play an important role in the neuroprotection of CNS
neurons [44, 45]. Recent reports have suggested that phy-
tochemicals can activate Nrf2 by directly binding to Keap1
through covalent linkages, resulting in the induction of
somecytoprotectiveproteins,includingHO-1.Inthepresent
study, we showed that NNMBS275 signiﬁcantly increased
Nrf2 levels and eﬃciently promoted its translocation into
the nucleus in both BV2 microglia and HT22 cells. This
suggests that Nrf2 may play an essential role in NNMBS275-
induced HO-1 expression. Since NNMBS275, as shown in
this study, can actively induce the expression of HO-1 in
mouse hippocampal HT22 cells and BV2 microglia, it is
possible that the antioxidative and anti-inﬂammatory eﬀects
of NNMBS275 are partly mediated by the products of
the HO-1 enzyme reaction, namely, CO, bilirubin and/or
biliverdin.
It is also well known that NF-κB is a signiﬁcant role
factor regulating the expression of inﬂammation-associated
enzymes and cytokine genes, such as iNOS, COX-2, TNF-α,
and IL-1β,wh i c hc o n t a i nN F - κB-binding motifs within their
respective promoters [46]. Many anti-inﬂammatory agents
exhibit their potency by suppressing NF-κB signaling [47,
48]. In this study, we examined the eﬀects of NNMBS275 on
thephosphorylation ofIκBαandthenucleartranslocationof
aN F - κB subunit, p65, in BV2 cells. As shown in Figure 9, the
phosphorylation and degradation of IκBα and the nuclear
translocation of p65 induced by LPS were signiﬁcantly
reduced after pretreatment with NNMBS275. Furthermore,
we also observed the appearance of NF-κB-DNA-binding
activity of NF-κB in nuclear extracts of BV2 cells stimulated
with LPS. These results suggest that NNMBS275, at least
in LPS-stimulated BV2 cells, exerted its anti-inﬂammatory
eﬀects by suppressing the expression of the proinﬂammatory
enzymes as well as the production of the proinﬂammatory
cytokines.
In conclusion, NNMBS275, the ethanol extract of V.
patrinii, showed potent anti-inﬂammatory eﬀects on mi-
croglial activation by LPS, possibly through the Nrf2 path-
way-dependent expression of HO-1 and suppression of NF-
κB signaling. Furthermore, we investigated the cytoprotec-
tive eﬀects of NNMBS275 on glutamate-induced neuro-
toxicity in mouse hippocampal HT22 cells via the HO-1
expression (Figure 10). The results of our study demonstrate
the importance of HO-1 in mediating the antioxidative
and anti-inﬂammatory eﬀects of NNMBS275 in mouse
microglial and hippocampal cells and reveal the possible
therapeutic value of NNMBS275 in preventing the progres-
sion of neurodegenerative disease. Further detailed chemical
studies of NNMBS275 would help to clarify its therapeutic
potential.
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